Fertility Frontiers: What Is a 'Permitted' Embryo in Law?
By Antony Starza-Allen,
Progress Educational Trust
| 06. 13. 2022
The question of what is a 'permitted embryo' under the legislation governing assisted reproduction in the UK has received increasing scrutiny as technological progress challenges the concept of embryohood. As illustrated at Progress Educational Trust (PET)'s event, 'Fertility Frontiers: What Is a 'Permitted' Embryo in Law?', the answer is not solely concerned with the scope of what is permissible in assisted reproduction but goes to the very core of the UK's legislative approach to emerging reproductive technologies.
Introducing the debate, Sarah Norcross, director of PET, highlighted that while UK fertility law gives confidence and security during scientific change, the definition of an embryo, introduced under the Human Fertilisation and Embryology (HFE) Act 2008, is not fully scientifically aligned. Under the HFE Act 2008, an embryo for use in assisted reproduction must have been created by the fertilisation of an unaltered 'permitted egg' with a 'permitted sperm'. It must have no cells added to it from other sources or have its DNA altered (an exception exists for mitochondrial donation). Recent technological developments have, however, challenged...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...